Development of Mastitis in a Mouse Infection Model from Four Bovine Isolates

A Nutrigenomics Study

Authors

  • A. Rowson OmniGen Research, Immunology, Corvallis, OR
  • E. Aalseth Dairy Health Consulting, Lake Stevens, WA
  • Y. Wang OmniGen Research, Immunology, Corvallis, OR
  • N. E. Forsberg OmniGen Research, Immunology, Corvallis, OR
  • S. B. Puntenney OmniGen Research, Immunology, Corvallis, OR

DOI:

https://doi.org/10.21423/aabppro20084495

Keywords:

feed supplement, OmniGen-AF, mastitis, somatic cell counts, severity, development

Abstract

The goal of this study was to evaluate the ability of a commercially-available feed supplement (OmniGen-AF) to reduce development of mastitis in a mouse mastitis model. The rationale for completing this study was two-fold. First, dairy producers have reported that OmniGen-AF reduced somatic cell counts and reduced mastitis after the introduction of the product into herds. Second, recent studies have shown that the product increased markers of both innate and adaptive immunity. Our hypothesis, therefore, was that feeding the product would reduce the development and severity of mastitis in a mouse model. To assess this hypothesis, five experiments were completed with three bovine mastitis isolates. The isolates included Streptococcus uberis (S. uberis), Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus).

Downloads

Published

2008-09-25

Issue

Section

Posters